Fundz

Wugen, Inc. Appoints Jim Faulkner as Chief Technology Officer

PRIVATEFeb 26, 2025

Position

Chief Technology Officer

Company

Wugen

Jim Faulkner
jfaulkner@wugen.com
St. LouisBiotechnologyresearch

Description

Wugen, Inc. announced the appointment of Jim Faulkner, Ph.D., as their chief technology officer on an interim basis, emphasizing his expertise and experience in advancing cell and gene therapy.

Quick answer

Wugen, Inc. Appoints Jim Faulkner as Chief Technology Officer (February 26, 2025). Wugen is based in St. Louis, Missouri, United States.

Who is the new Chief Technology Officer at Wugen?
Wugen named Jim Faulkner Chief Technology Officer, announced February 26, 2025.
What did Wugen announce on February 26, 2025?
Wugen, Inc. announced the appointment of Jim Faulkner, Ph.D., as their chief technology officer on an interim basis, emphasizing his expertise and experience in advancing cell and gene therapy.
What does Wugen do?
Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer.
Where is Wugen based?
Wugen is based in St. Louis, Missouri, United States.
Which similar companies made leadership changes around the same time?
Climb Bio, Inc. (February 25, 2025), Affinia Therapeutics (February 5, 2025), Akari Therapeutics (March 20, 2025) and Cantargia AB (April 1, 2025) also announced leadership changes within 45 days of Wugen.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Wugen, and when

A new leader at Wugen brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Wugen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Wugen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Wugen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Wugen

Location

4260 Forest Park Ave., Suite 100

St. Louis, Missouri, United States

About

Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Wugen changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Keith
Likely contact at this company
••••••••@••••••••

See Keith's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Wugen's next move

Learn about Strategic plan

Wugen changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.